Association between interleukin-6 gene promoter 2572C/G polymorphism and the risk of sporadic Alzheimer's disease

Neurological Sciences

Volumn 31, Issue 2, 2010, Pages 165-168

  He, Mei Xia ^a   Yang, Wan Li ^a   Zhang, Ming Ming ^a   Lian, Ya Jun ^b   Hua, Hai Ying ^a   Zeng, Jin Sheng ^c   Zhang, Li Rong ^a  

^a ZHENGZHOU UNIVERSITY   (China)

^b THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^c SUN YAT SEN UNIVERSITY   (China)

Author keywords

Alzheimer's disease; Interleukin 6; Polymorphism

Indexed keywords

INTERLEUKIN 6;

AGED; ALZHEIMER DISEASE; ARTICLE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENETIC ASSOCIATION; GENETIC LINKAGE; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROMOTER REGION;

AGED, 80 AND OVER; ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; INTERLEUKIN-6; LOGISTIC MODELS; MALE; ODDS RATIO; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 77953542774     PISSN: 15901874     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10072-009-0199-3     Document Type: Article

References (27)

1. Walsh DM, Selkoe DJ (2004) Deciphering the molecular basis of memory failure in Alzheimer's disease. Neuron 44:181-193
2. Aisen PS (1997) Inflammation and Alzheimer's disease: mechanisms and therapeutic strategies. Gerontology 43:143-149
3. Ge YW, Lahiri DK (2002) Regulation of promoter activity of the APP gene by cytokines and growth factors: implications in Alzheimer's disease. Ann N Y Acad Sci 973:463-467
4. Bagli M, Papassotiropoulos A, Knapp M, Jessen F, Luise Rao M, Maier W, Heun R (2000) Association between an interleukin-6 promoter and 30 flanking region haplotype and reduced Alzheimer's disease risk in a German population. Neurosci Lett 283:109-112
5. Faltraco F, Bürger K, Zill P, Teipel SJ, Möller HJ, Hampel H, Bondy B, Ackenheil M (2003) Interleukin-6-174 G/C promoter gene polymorphism C allele reduces Alzheimer's disease risk. J Am Geriatr Soc 51:578-579
6. Pola R, Flex A, Gaetani E, Lago AD, Gerardino L, Pola P, Bernabei R (2002) The -174 polymorphism of the interleukin-6 gene is associated with Alzheimer's disease in an Italian population. Neuroreport 13:1645-1647
7. Licastro F, Grimaldi LM, Bonafè M, Martina C, Olivieri F, Cavallone L, Giovanietti S, Masliah E, Franceschi C (2003) Interleukin-6 gene alleles affect the risk of Alzheimer's disease and levels of the cytokine in blood and brain. Neurobiol Aging 24:921-926
8. Shibata N, Ohnuma T, Takahashi T, Baba H, Ishizuka T, Ohtsuka M, Ueki A, Nagao M, Arai H (2002) Effect of IL-6 polymorphism on risk of Alzheimer's disease: genotype-phenotype association study in Japanese cases. Am J Med Genet 114:436-439 (Pubitemid 34525242)
9. Haddy N, Sass C, Maumus S, Marie B, Droesch S, Siest G, Lambert D, Visvikis S (2005) Biological variations, genetic polymorphisms and familial resemblance of TNF-alpha and IL-6 concentrations: STANISLAS cohort. Eur J Hum Genet 13:109-117
10. Tobinick E, Gross H, Weinberger A, Cohen H (2006) TNF-alpha modulation for treatment of Alzheimer's disease: a 6-month pilot study. MedGenMed 8:25
11. Folstein MF, Folstein SE, McHugh PR (1975) "Mini-mental state". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189-198
12. Zheng C, Huang DR, Bergenbrant S, Sundblad A, Osterborg A, Björkholm M, Holm G, Yi Q (2000) Interleukin 6, tumour necrosis factor alpha, interleukin 1beta and interleukin 1 receptor antagonist promoter or coding gene polymorphisms in multiple myeloma. Br J Haematol 109:39-45
13. Buraczynska M, Jozwiak L, Ksiazek P, Borowicz E, Mierzicki P (2007) Interleukin-6 gene polymorphism and faster progression to end-stage renal failure in chronic glomerulonephritis. Transl Res 150:101-105
14. Faul F, Erdfelder E, Lang A-G (2007) G*Power 3: a flexible statistical power analysis program for the social, behavioral, and biomedical sciences. Behav Res Methods 39:175-191
15. Cardellini M, Perego L, D'Adamo M, Marini MA, Procopio C, Hribal ML, Andreozzi F, Frontoni S, Giacomelli M, Paganelli M, Pontiroli AE, Lauro R, Folli F, Sesti G (2005) C-174G polymorphism in the promoter of the interleukin-6 gene is associated with insulin resistance. Diabetes Care 28:2007-2012
16. Chapman CM, Beilby JP, Humphries SE, Palmer LJ, Thompson PL, Hung J (2003) Association of an allelic variant of interleukin-6 with subclinical carotid atherosclerosis in an Australian community population. Eur Heart J 24:1494-1499
17. Fan LY, Tu XQ, Zhu Y, Pfeiffer T, Feltens R, Stoecker W, Zhong RQ (2005) Genetic association of cytokines polymorphisms with autoimmune hepatitis and primary biliary cirrhosis in the Chinese. World J Gastroenterol 11:2768-2772 (Pubitemid 40704245)
18. Chung HW, Seo JS, Hur SE, Kim HL, Kim JY, Jung JH, Kim LH, Park BL, Shin HD (2003) Association of interleukin-6 promoter variant with bone mineral density in pre-menopausal women. J Hum Genet 48:243-248
19. Zhai R, Liu G, Yang C, Huang C, Wu C, Christiani DC (2001) The G to C polymorphism at -174 of the interleukin-6 gene is rare in a Southern Chinese population. Pharmacogenetics 11:699-701
20. Pyo CW, Hur SS, Kim YK, Choi HB, Hong YS, Kim DW, Kim CC, Kim HK, Kim TG (2003) Polymorphisms of IL-1B, IL-1RN, IL-2, IL-4, IL-6, IL-10, and IFN-gamma genes in the Korean population. Hum Immunol 64:979-989
21. Schluter B, Raufhake C, Erren M, Schotte H, Kipp F, Rust S, Van Aken H, Assmann G, Berendes E (2002) Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis. Crit Care Med 30:32-37
22. Colhoun HM, McKeigue PM, Davey Smith G (2003) Problems of reporting genetic associations with complex outcomes. Lancet 361:865-872
23. Strauss S, Bauer J, Ganter U, Jonas U, Berger M, Volk B (1992) Detection of interleukin-6 and alpha 2-macroglobulin immunoreactivity in cortex and hippocampus of Alzheimer's disease patients. Lab Invest 66:223-230
24. Vandenabeele P, Fiers W (1991) Is amyloidogenesis during Alzheimer's disease due to an IL-1-/IL-6-mediated 'acute phase response' in the brain? Immunol Today 12:217-219
25. Campbell IL, Stalder AK, Chiang CS, Bellinger R, Heyser CJ, Steffensen S, Masliah E, Powell HC, Gold LH, Henriksen SJ, Siggins GR (1997) Transgenic models to assess the pathogenic actions of cytokines in the central nervous system. Mol Psychiatry 2:125-129
26. Yucesoy B, Peila R, White LR, Wu KM, Johnson VJ, Kashon ML, Luster MI, Launer LJ (2006) Association of interleukin-1 gene polymorphisms with dementia in a community-based sample: the Honolulu-Asia Aging Study. Neurobiol Aging 27:211-217
27. Wang B, Zhou S, Yang Z, Xie YC, Wang J, Zhang P, Lv Z, Zheng C, Ma X (2008) Genetic analysis of tumor necrosis factoralpha (TNF-alpha) G-308A and Saitohin Q7R polymorphisms with Alzheimer's disease. J Neurol Sci 270:148-151